Clinical Trial Update: CyFluATG in Lower Risk MDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CyFluATG in lower risk myelodysplastic syndromes (MDS) shows the study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• CyFluATG

Snippet

Sponsor: Asan Medical Center | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: ACTIVE_NOT_RECRUITING